Evidence map›Paper›PMID 34732801›Full record

ArticleScientific reports2021

Gene-level analysis of rare variants in 379,066 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes.

Aimee M Deaton, Margaret M Parker, Lucas D Ward, Alexander O Flynn-Carroll, Lucas BonDurant, Gregory Hinkle, Parsa Akbari, Luca A Lotta, Regeneron Genetics Center, DiscovEHR Collaboration and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Systematic common and rare variant association testing in 392,030 whole genomes inmedRxiv : the preprint server for health sciences · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Aimee M DeatonAlnylam Pharmaceuticals, Cambridge, MA, USA. adeaton@alnylam.com.
Margaret M ParkerAlnylam Pharmaceuticals, Cambridge, MA, USA.
Lucas D WardAlnylam Pharmaceuticals, Cambridge, MA, USA.
Alexander O Flynn-CarrollAlnylam Pharmaceuticals, Cambridge, MA, USA.
Lucas BonDurantAlnylam Pharmaceuticals, Cambridge, MA, USA.
Gregory HinkleAlnylam Pharmaceuticals, Cambridge, MA, USA.
Parsa AkbariRegeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, NY, USA.
Luca A LottaRegeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, NY, USA.
Regeneron Genetics Center
DiscovEHR Collaboration
Aris BarasRegeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, NY, USA.
Paul NioiAlnylam Pharmaceuticals, Cambridge, MA, USA.
Regeneron (United States) · USGeisinger Health System · USAlnylam Pharmaceuticals (United States) · US

Funding

Medical Research Council MC_PC_17228Medical Research Council MC_QA137853
6 · The paper itself

Abstract

Sequencing of large cohorts offers an unprecedented opportunity to identify rare genetic variants and to find novel contributors to human disease. We used gene-based collapsing tests to identify genes associated with glucose, HbA1c and type 2 diabetes (T2D) diagnosis in 379,066 exome-sequenced participants in the UK Biobank. We identified associations for variants in GCK, HNF1A and PDX1, which are known to be involved in Mendelian forms of diabetes. Notably, we uncovered novel associations for GIGYF1, a gene not previously implicated by human genetics in diabetes. GIGYF1 predicted loss of function (pLOF) variants associated with increased levels of glucose (0.77 mmol/L increase, p = 4.42 × 10

Indexed as

Genetic VariationCarrier ProteinsCholesterolDiabetes Mellitus, Type 2ExomeExome SequencingFemaleGenetic Predisposition to DiseaseGenetic TestingGenome, HumanGenome-Wide Association StudyGlucoseHepatocyte Nuclear Factor 1-alphaHomeodomain ProteinsHumansHypothyroidismCarrier ProteinsCholesterolGIGYF1 protein, humanGlucoseHepatocyte Nuclear Factor 1-alphaHNF1A protein, humanHomeodomain Proteinspancreatic and duodenal homeobox 1 proteinTrans-Activators

Identifiers

PMID34732801
PMCPMC8566487
OpenAlexW3208002743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.